Stock Events

Stock Events

Axogen 

$48.28
26
+$1.18+2.51% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
48.34
Day Low
48.26
52W High
52.91
52W Low
15.27
Volume
20,623
Avg. Volume
-
Mkt Cap
2.6B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Feb 10
$1.00
Mar 5
$0.06
Feb 5
$0.06
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.02
0.03
0.08
0.13
Expected EPS
0.1275
Actual EPS
N/A

Financials

-6.97%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
225.21MRevenue
-15.7MNet Income

Analyst Ratings

53.50Average Price Target
The highest estimate is 60.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
17%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AXGN. It's not an investment recommendation.
NVIDIA
11
NVDA
Amazon
10
AMZN
Altria Group
9
MO
Johnson & Johnson
8
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation offers a range of medical technologies, including neurotechnology and spine products that compete with Axogen's nerve repair solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc provides medical devices used in various surgical procedures, including those for nerve repair and protection, directly competing with Axogen's product offerings.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences Holdings Corporation offers products for neurosurgery and reconstructive surgery, competing in the same nerve repair market as Axogen.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. has a portfolio that includes surgical solutions for nerve damage, which competes with Axogen's nerve repair and regeneration products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation manufactures medical devices used in interventional medical specialties, including neuromodulation, competing with Axogen in the broader nerve repair market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary DePuy Synthes, offers products for neurosurgery and orthopaedics that compete with Axogen's nerve repair solutions.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc., through its acquisition of Allergan, has entered into the neuromodulation market, which puts it in competition with Axogen's nerve therapy solutions.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a range of hospital and surgical products, including those for nerve repair, competing with Axogen in the healthcare solutions sector.
Align Technology
ALGN
Mkt Cap11.19B
Align Technology, Inc., though primarily known for its dental products, has ventured into the medical device sector, potentially overlapping with Axogen's market in future developments.

About

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Show more...
CEO
Michael D. Dale
Employees
622
Country
United States
ISIN
US05463X1063
WKN
000A1JMHK

Listings

LSE
GB
0HKD.LSE
STU
DE
LT3.STU
MX
MX
AXGN.MX
XNAS
US
AXGN

0 Comments

Share your thoughts

FAQ

What is Axogen stock price today?▼
The current price of AXGN is $48.28 USD — it has increased by +2.51% in the past 24 hours. Watch Axogen stock price performance more closely on the chart.
What is Axogen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Axogen stocks are traded under the ticker AXGN.
Is Axogen stock price growing?▼
AXGN stock has fallen by -6.2% compared to the previous week, the month change is a +6.77% rise, over the last year Axogen has showed a +202.13% increase.
What is Axogen market cap?▼
Today Axogen has the market capitalization of 2.6B
When is the next Axogen earnings date?▼
Axogen is going to release the next earnings report on November 10, 2026.
What were Axogen earnings last quarter?▼
AXGN earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.12 USD resulting in a -1.18% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Axogen revenue for the last year?▼
Axogen revenue for the last year amounts to 225.21M USD.
What is Axogen net income for the last year?▼
AXGN net income for the last year is -15.7M USD.
Does Axogen pay dividends?▼
Yes, AXGN dividends are paid en. The last dividend per share was 1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Axogen have?▼
As of September 05, 2026, the company has 622 employees.
In which sector is Axogen located?▼
Axogen operates in the Health & Wellness sector.
When did Axogen complete a stock split?▼
Axogen has not had any recent stock splits.
Where is Axogen headquartered?▼
Axogen is headquartered in ALACHUA, United States.